Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Titel:
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Auteur:
Solinas, C. Ceppi, M. Lambertini, M. Scartozzi, M. Buisseret, L. Garaud, S. Fumagalli, D. de Azambuja, E. Salgado, R. Sotiriou, C. Willard-Gallo, K. Ignatiadis, M.